Clinical trial

Sitagliptin/Metformin (JANUMET) Re-examination Study (0431A-182)

NCT01065766

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2009-03-01

PhaseN/A

Study timeline

Study start (unknown)2009-03-01Date precision: month

Registry last updated2015-03-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitusunresolved

Interventions

Sitagliptin/metforminDRUG

Sponsors & collaborators

Merck Sharp & Dohme LLClead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01065766 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.